RSV Awareness Week Reveals Alarming Lack of Understanding Among At-Risk Adults in Spain
Table of Contents
Despite growing awareness of respiratory illnesses, a new international survey reveals a significant gap in knowledge regarding Respiratory Syncytial Virus (RSV) among adults over 50 with chronic diseases in Spain. The findings, released during RSV Awareness Week (November 3-9), indicate that many are unaware of the virus’s potential severity and the preventative measures available.
Only two in five adults in this vulnerable group recognize RSV as a potentially serious illness, despite being at higher risk of complications and hospitalization. The study, promoted by the biopharmaceutical company GSK, also found that over half (51%) have never discussed RSV with a healthcare professional, and among those who have, only 27% received information about prevention.
Risk Perception Lags Behind General Knowledge
While awareness of RSV in Spain is reportedly higher than the global average, this knowledge doesn’t necessarily translate into a heightened sense of risk. A concerning 38% of those over 50 with chronic conditions even know what the acronym VRS – the Spanish equivalent of RSV – means. Misconceptions are prevalent, with 28% believing RSV is simply a type of flu and 29% thinking it only affects the lungs. Alarmingly, 21% of respondents expressed no worry at all about contracting the virus.
This lack of awareness is particularly troubling for individuals with conditions like diabetes, chronic obstructive pulmonary disease (COPD), asthma, coronary heart disease, or heart failure, as these groups are at the highest risk of developing severe respiratory infections.
Among Spanish participants, 53% of those with COPD and 41% with diabetes acknowledge their increased vulnerability to infections like flu or pneumonia. However, a significantly lower 22% of patients with cardiovascular diseases perceive this added risk.
RSV: More Than Just a Common Cold
“RSV is not the same as a common cold or flu,” cautioned a medical director from the Global Respiratory Allergy Patient Platform (GAAPP). “For adults with certain underlying illnesses, it poses a risk of serious illness and may aggravate existing chronic illnesses. However, because the general public perceives its symptoms as mild, its dangerousness in people at risk is often overlooked.”
Despite 83% of at-risk adults reporting they are well-informed about their medical conditions, only 27% feel “definitely” at greater risk of serious respiratory infections, and just 26% are “very worried” about developing them.
Communication gaps also exist between patients and healthcare providers. While nearly half (49%) of respondents have discussed RSV with their doctor, only a quarter of those conversations included information on preventative measures. Consultations primarily occur with primary care physicians (43%), followed by nursing professionals (33%), pharmacists (32%), and other specialists (31%).
This limited dialogue underscores that RSV doesn’t yet receive the attention it deserves in conversations about respiratory health, despite its potential to cause serious symptoms in older adults and those with chronic diseases.
Serious Consequences and the Need for Increased Awareness
This general ignorance can have significant consequences. Approximately 14% of adults hospitalized with RSV require a higher level of care upon discharge compared to their previous health status. In Spain, 43% of COPD patients are unaware of the risk of hospital admission associated with RSV, and over half of those with heart disease or diabetes have never discussed the issue with their doctor.
Key findings from the survey in Spain include:
- 80% of those over 50 with chronic diseases are concerned about contracting serious respiratory infections, yet only 55% are aware that RSV can be serious.
- Only 26% of at-risk adults in Spain express “very worried” sentiments, while 21% report no worry at all.
- 66% of individuals with cardiovascular disease are unaware of their risk of serious heart complications, despite being more than three times as likely to experience an acute cardiac event or worsening heart failure if hospitalized for RSV.
- Misconceptions persist, with 28% incorrectly believing RSV is a flu virus and 29% believing it only affects the lungs.
A Call for Improved Communication and Prevention
María José Muñoz, medical director of GSK Spain, emphasized the need for continued education and prevention efforts. “This survey is a reminder that RSV continues to be an underestimated and misunderstood threat, especially for people at higher risk of suffering from serious illness,” she stated. “This RSV Awareness Week represents an opportunity to continue to improve awareness, empower people to understand their real risk, and encourage conversations with healthcare professionals about this respiratory infection and its potential to worsen underlying conditions.”
RSV causes over five million infections annually worldwide, disproportionately impacting children and older adults with chronic conditions. Despite improvements in general knowledge, low risk perception highlights the importance of strengthening communication between patients and healthcare professionals.
RSV Awareness Week aims to increase the visibility of this virus, promote health education, and encourage proactive prevention among the most vulnerable populations.
